ELDEPRYL (selegiline hydrochloride) capsule [Somerset ...
ELDEPRYL (selegiline hydrochloride) is a levorotatory acetylenic derivative of phenethylamine. It is commonly referred to in the clinical and ...
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f11be...
|
Selegiline (Eldepryl) for Parkinson's disease.
Selegiline (Eldepryl) for Parkinson's disease. C. H. Waters. Full text. Full text is available as a scanned copy of the original print version. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1002921/...
|
Eldepryl (selegiline hydrochloride) Capsules December 2008
19 Jun 2009 ... Eldepryl (selegiline hydrochloride) Capsules December 2008. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ...
METHODS: Three groups of C57BL mice were treated with MPTP, Eldepryl plus MPTP and normal saline, respectively, for 7 days before performing TUNEL (terminal
...
http://www.ncbi.nlm.nih.gov/pubmed/11780305...
|
Selegiline - Wikipedia, the free encyclopedia
Selegiline (l-deprenyl, Eldepryl) is a drug used for the treatment of early- stage Parkinson's disease, depression and senile dementia. ...
http://en.wikipedia.org/wiki/Selegiline...
|
Side effects of selegiline (Eldepryl).
Selegiline (Eldepryl), recently approved as an adjunct to levodopa-carbidopa ( Sinemet), was administered to eight patients with Parkinson's disease in an ...
http://www.ncbi.nlm.nih.gov/pubmed/1571071...
|
NDA 21-336 EMSAM (selegiline transdermal sysytem
A comparison of EMSAM 20mg with Eldepryl (oral selegiline 5mg bid) for 9-10 days ... Oral selegiline (Eldepryl) has been marketed for several years without ...
http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4186S2_02...
|
Selegiline (Eldepryl) for Parkinson's disease.
Selegiline (Eldepryl) for Parkinson's disease. Waters CH. Mesh Terms: Drug Therapy, Combination; Humans; Levodopa/therapeutic use; Parkinson Disease/drug
...
http://www.ncbi.nlm.nih.gov/pubmed/1908608...
|
Parkinson's Disease: Movement and Cerebellar Disorders: Merck ...
and continuing it for the first 2 mo of treatment. Selective monoamine oxidase type B (MAO-B) inhibitors: Selegiline Some Trade Names ELDEPRYL ...
http://www.merck.com/mmpe/sec16/ch221/ch221g.html...
|
Anti-Parkinson Agents - Pharmacy Clinical Policy Bulletins Aetna ...
Aetna considers Akineton, Cogentin, Eldepryl, Kemadrin, Larodopa, Lodosyn, Neupro, Parcopa, Parlodel, Sinemet, Sinemet CR, Symmetrel, Tasmar and Zelapar to
...
http://www.aetna.com/products/rxmedicare/data/Medicare2007/C...
|
